SMSLIFE — SMS Lifesciences India Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual income statement for SMS Lifesciences India, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	3,779	2,608	2,656	3,497	3,156
Cost of Revenue
Gross Profit	755	663	837	976	946
Selling / General / Administrative Expenses
Depreciation and Amortization
Total Operating Expenses	3,494	2,432	2,433	3,256	2,976
Operating Profit	285	176	223	242	180
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	254	147	196	327	166
Provision for Income Taxes
Net Income After Taxes	178	102	136	253	114
Minority Interest
Net Income Before Extraordinary Items
Net Income	178	102	136	253	115
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	178	102	136	253	115
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	59.2	33.6	44.8	63.5	32.6
Dividends per Share